NCT03310983View on ClinicalTrials.gov

Growth and Adiposity in Newborns: The Influence of Prenatal Docosahexaenoic Acid (DHA) Supplementation

CompletedOBSERVATIONAL

Enrollment

254

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions

Pregnancy; Nutritional Diseases

Trial Locations (1)

66160

The University of Kansas Medical Center, Kansas City

All Listed Sponsors

lead

University of Kansas Medical Center

OTHER

NCT03310983 - Growth and Adiposity in Newborns: The Influence of Prenatal Docosahexaenoic Acid (DHA) Supplementation | Biotech Hunter | Biotech Hunter